3 Broker Favorite Biopharmas Your Portfolio Must Have Post author:Sam Post published:January 17, 2018 Post category:BioPharma These stocks have been given a Strong Buy or Buy rating by 80% or more brokers. Source: BioSpace You Might Also Like The Single Best Hep C Drug Stock to Buy in 2017—Hint, It's Not Gilead June 8, 2017 Pfizer Sheds More After Unloading Medivation's Mission Bay Space May 8, 2017 PAREXEL Sold to Investment Firm in $5 Billion Deal June 19, 2017
